ArticleClinical pharmacology and therapeutics2026
Reprocessing Mass Spectra from Therapeutic Drug Monitoring to Unveil Proton Pump Inhibitor Use and Quantify Phenoconversion of Escitalopram Metabolism in CYP2C19-Genotyped Patients.
Kristine Hole et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.